Thermo Fisher Scientific acquires TREK Diagnostic Systems

Keith Moore | | Health Imaging | Enterprise Imaging
Thermo Fisher Scientific has acquired TREK Diagnostic Systems from Magellan Biosciences.

Cleveland-based TREK Diagnostic Systems, a provider of microbiology platforms, including blood culture, microorganism identification and antibiotic susceptibility testing products, currently serves pharmaceutical and clinical laboratory markets and will be integrated into Thermo Fisher’s Analytical Technologies Segment, according to the Waltham, Mass.-based developer of scientific technology.

Keith Moore

Related Content

Do large language models help or hinder workflows related to radiology reports?
Telehealth visits not to blame for uptick in imaging orders, study shows
Up to half of medical organizations either already using or preparing to implement AI
Radiology practice's communication failure bears tragic consequences
Less than half of incidental interstitial lung abnormalities on CT exams are reported
Are providers too trusting of AI's advice?

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.